Understanding Your Lab Test: What It Is, How It's Done, and Why It Matters
This test detects genetic mutations in the ahpC gene that may cause antibiotic resistance in bacteria, particularly tuberculosis.
{"Detects genetic changes (mutations) in bacteria that may cause drug resistance","Helps doctors choose the right antibiotics for treatment","Uses a blood serum sample and advanced molecular technology","Mainly used for tuberculosis (TB) bacteria testing","Results help guide personalized treatment plans"}
Key facts at a glance
- LOINC
- 94057-7
- Short code
- AHPCRES
- Synonyms
- Bacterial ahpC drug res mut Islt/Spm
- Category
- chemistry
- Sample
- serum
- Container
- Sterile, leak-proof container for bacterial isolates or appropriate transport medium; for serum samples use serum separator tube (SST) or plain red-top tube
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- molgen
- CPT
- 87541
- SNOMED
- 398235005
- Specimen volume
- 1-5 mL serum or bacterial isolate in appropriate transport medium
- Stability
- Refrigerate at 2-8°C; process within 24 hours or freeze at -70°C for extended storage. Bacterial isolates stable in transport medium per manufacturer's specifications
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 24–72 hours
- Order
- routine
This is a laboratory test that helps your healthcare provider evaluate important aspects of your health. It may be ordered as part of a routine checkup, to investigate specific symptoms, or to monitor an ongoing condition and see how well your current treatment is working.
The Bacterial ahpC Gene Drug Resistance Mutation test is a molecular diagnostic test that looks for specific genetic changes (mutations) in the ahpC gene of bacteria. The ahpC gene is found in bacteria like Mycobacterium tuberculosis (the germ that causes tuberculosis). When this gene has certain mutations, it can make the bacteria resistant to antibiotics, particularly isoniazid (a common TB medicine). This test uses advanced laboratory methods to detect these genetic changes directly from your blood sample.
The test is performed by a trained member of our care team, who will explain each step before it begins. Depending on what your provider ordered, a small sample of blood, urine, or another specimen may be collected. A blood draw usually takes only a few minutes and may cause brief, mild discomfort. After collection, the sample is sent to the laboratory for analysis, and your results are shared with your provider, who will review them with you.
A healthcare provider will collect a blood sample from your vein. The sample is then sent to a laboratory where scientists use molecular techniques (such as polymerase chain reaction or PCR) to examine the bacterial DNA in your blood. The test looks specifically for mutations in the ahpC gene that are known to cause antibiotic resistance. Results are typically available within a few days to a week, depending on the laboratory.
This test provides objective information about your health that symptoms alone cannot show. It can help confirm or rule out a condition, guide treatment decisions, track changes over time, and detect potential problems early, when they are often easier to address. Completing the test as ordered helps ensure your provider has the information needed to care for you effectively.
This test is important because antibiotic resistance is a growing problem worldwide. If bacteria like TB become resistant to standard antibiotics, treatment becomes much more difficult. By detecting these genetic mutations early, doctors can choose more effective antibiotics right from the start, leading to better treatment outcomes and helping prevent the spread of drug-resistant infections.
Reference range
Negative (no ahpC gene drug resistance mutations detected). Positive indicates presence of mutations conferring resistance. Results reported as mutation detected or not detected with specific mutation identification when applicableN/A
No special patient preparation required. Specimen should be collected prior to initiation of antimicrobial therapy when possible. Inform laboratory of current or recent antibiotic use as this may affect results
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
The ahpC gene mutation test has significant clinical value in managing tuberculosis and other bacterial infections. Mutations in the ahpC gene are associated with resistance to isoniazid, one of the most important first-line antibiotics for TB treatment. Detecting these mutations helps clinicians: (1) Confirm drug-resistant TB earlier, (2) Adjust treatment regimens promptly to include effective medications, (3) Prevent prolonged use of ineffective antibiotics that could worsen resistance, and (4) Improve patient outcomes by enabling personalized treatment plans. This test is particularly crucial in regions with high TB prevalence or where drug-resistant TB is common.
Frequently asked questions
Who needs this test?
Does the test hurt?
How long does it take to get results?
What do the results mean?
Do I need to prepare for the test?
Sources
- 1
- 2
- 3LOINC Code ReferenceSource
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy